Efficacy and Safety of Qishenyiqi Dripping Pills for Treating Chronic Heart Failure With Preserved Ejection Fraction

PHASE2CompletedINTERVENTIONAL
Enrollment

225

Participants

Timeline

Start Date

July 27, 2021

Primary Completion Date

December 19, 2024

Study Completion Date

December 19, 2024

Conditions
Chronic Heart Failure With Preserved Ejection Fraction
Interventions
DRUG

Qishen Yiqi dripping pills 2 bags/time + Qishen Yiqi dripping pills placebo 2 bags/time

Take 3 times a day after meals,24 weeks

DRUG

Qishen Yiqi dripping pills 4 bags/time

Take 3 times a day after meals,24 weeks

DRUG

Qishen Yiqi dripping pills placebo 4 bags/time

Take 3 times a day after meals,24 weeks

Trial Locations (16)

Unknown

The First Affiliated Hospital of Bengbu Medical College, Bengbu

Beijing Hospital, Beijing

Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing

Xuanwu Hospital Capital Medical University, Beijing

Peking University People's Hospital, Beijing

The First Affiliated Hospital of Chongqing Medical University, Chongqing

Hebei General Hospital, Shijiazhuang

The Third Affiliated Hospital of Xinxiang Medical College, Xinxiang

The third Xiangya Hospital of Central South University, Changsha

Jiangsu Province Hospital, Nanjing

Zhongda Hospital Southeast University, Nanjing

China Japan Union Hospital of Jilin University, Changchun

The Affiliated Hospital of Inner Mongolia Medical University, Hohhot

First Hospital of Shanxi Medical University, Taiyuan

The Second Affiliated Hospital Of Xi'an Jiaotong University, Xi’an

Tianjin Chest Hospital, Tianjin

All Listed Sponsors
lead

Tasly Pharmaceutical Group Co., Ltd

INDUSTRY

NCT04944706 - Efficacy and Safety of Qishenyiqi Dripping Pills for Treating Chronic Heart Failure With Preserved Ejection Fraction | Biotech Hunter | Biotech Hunter